Latest Lupus erythematosus Stories
HERZLIYA, Israel, March 25, 2014 /PRNewswire/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB, TASE: XTL) ("XTL" or the "Company"),
Discounted research study “PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022” elaborated by GlobalData is now available at MarketPublishers.com.
Lupus Research Organizations Welcome Big-Science Push to Drive New Therapies for Lupus Patients NEW YORK, Feb.
Lupus Foundation of America Joins a Five-Year Initiative to Bring Together Government, Academia, Industry and Nonprofit Health Organizations to Harness Capabilities and Resources
HERZLIYA, Israel, January 8, 2014 /PRNewswire/ -- XTL Biopharmaceuticals Ltd.
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.